Primary Site >> Biliary tract Cancer
Gene >> HDAC9
|
|
|
|---|---|---|
|
Ref: Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells. PMID: 17724801 |
Ref: Role of histone deacetylase expression in intrahepatic cholangiocarcinoma. PMID: 21982637 |
Ref: Phase I study of resminostat, an HDAC inhibitor, combined with S-1 in patients with pre-treated biliary tract or pancreatic cancer. PMID: 29995287 |